| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/16/2006 | WO2005097107A8 Diphenyl - indol-2-on compounds and their use in the treatment of cancer |
| 02/16/2006 | WO2005061496A8 Aminopyridine-derivatives as inductible no-synthase inhibitors |
| 02/16/2006 | US20060035922 pyrazolyl-[(triazolopyridinylsulfanyl)-benzyl]-urea derivatives; antiinflammatory agents; resiratory disorders, asthma, allergies; N-{3-tert-Butyl-1-[4-(methylthio)phenyl]-1H-pyrazol-5-yl}-N'-{2-[(3-isopropyl [1 ,2,4]triazolo[4,3-a]pyridin-6-yl)thio]benzyl}urea |
| 02/16/2006 | US20060035921 N3-substituted imidazopyridine c-Kit inhibitors |
| 02/16/2006 | US20060035920 Chk-1 inhibitors |
| 02/16/2006 | US20060035919 4-[4-(4-Amino-phenyl)-3-oxo-3,5-dihydro-pyrazolo[4,3-c]quinolin-2-yl]-benzoic acid methyl ester; rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis; CD80 antagonists capable of inhibiting the interactions between CD80 and CD28 |
| 02/16/2006 | US20060035892 Nitrosated imidazopyridines |
| 02/16/2006 | US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase |
| 02/16/2006 | US20060035876 Combination therapy of an SODm and a corticosteroid for prevention and/or treatment of inflammatory bone or joint disease |
| 02/16/2006 | CA2575808A1 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds |
| 02/16/2006 | CA2575571A1 2,8-disubstituted naphthyridine derivatives |
| 02/16/2006 | CA2568850A1 Indolizine carboxamides and the aza and diaza derivatives thereof |
| 02/15/2006 | EP1625127A1 Azaindole compounds as kinase inhibitors |
| 02/15/2006 | EP1625126A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 02/15/2006 | EP1625119A1 Substituted-1-phthalazinamines as vr-1 antagonists |
| 02/15/2006 | EP1233743B1 Compositions for dyeing keratinous fibres containing 3-amino pyrazolo-[1,5-a]-pyridines, dyeing method, novel 3-amino pyrazolo-[1,5-a]-pyridines |
| 02/15/2006 | EP1010423B1 Oral pharmaceutical preparation comprising an antiulcer benzimidazole derivative, and process for its production |
| 02/15/2006 | CN1735619A Spirocyclic cyclohexane compounds |
| 02/15/2006 | CN1735618A New tricyclic derivatives as LTD4 antagonists |
| 02/15/2006 | CN1735613A 稠合杂环化合物 Fused heterocyclic compounds |
| 02/15/2006 | CN1735612A Anti-infective agents |
| 02/15/2006 | CN1735605A Phenylalanine derivatives as depeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/15/2006 | CN1735600A 3-phenyl-cinnoline homologue and antitumor agent containing the same |
| 02/15/2006 | CN1735595A Substituted alkyl amido piperidines |
| 02/15/2006 | CN1733764A 3-substituted nalidixic acid analog compound and its preparation method and uses in pharmacy |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1241926C Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 02/15/2006 | CN1241925C New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them |
| 02/15/2006 | CN1241924C Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 02/15/2006 | CN1241923C Method for extracting total alkaloid of corydalis rhizome and its new usage |
| 02/14/2006 | US6998487 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties |
| 02/14/2006 | US6998485 3a,8a-Bis-azidomethyl-3a,4,8a,9-tetrahydro-3H,8H-bis[1,2,3]triazolo[1,5-a;1'',5''-d]pyrazine; provides low molecular weight energetic compounds with multiple energetic groups |
| 02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
| 02/14/2006 | US6998399 cognition activators; prevention of nicotinic receptors dysfunction, central nervous system; Alzheimer's disease, Parkinson's disease, Huntington's chorea, neurodegenerative diseases |
| 02/14/2006 | US6998368 Wear resistance; oil additive |
| 02/14/2006 | US6997983 Perylene pigment composition and process therefor |
| 02/14/2006 | CA2250863C Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 02/14/2006 | CA2241094C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2241093C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2209825C Heterocyclic-fused pyridines |
| 02/14/2006 | CA2192645C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2192644C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2192643C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2189567C Substituted fused and bridged bicyclic compounds as therapeutic agents |
| 02/14/2006 | CA2105666C New centrally acting substituted phenylazacycloalkanes |
| 02/09/2006 | WO2006015124A2 Fused ring heterocycle kinase modulators |
| 02/09/2006 | WO2006014136A1 Piperidine derivatives as histamine h3 receptor ligands |
| 02/09/2006 | WO2006014135A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 02/09/2006 | WO2006013195A1 5-substituted 1h-pyrrolo[3,2-b]pyridines |
| 02/09/2006 | WO2006013095A2 Condensed pyridines as kinase inhibitors |
| 02/09/2006 | WO2005108405A3 Lanthanide chelates and use thereof in bioanalysis |
| 02/09/2006 | WO2005062795A3 Compounds and methods for development of ret modulators |
| 02/09/2006 | WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030610 Method of treating inflammatory diseases |
| 02/09/2006 | US20060030605 Pharmaceutical compounds |
| 02/09/2006 | US20060030584 2,8-Disubstituted naphthyridine derivatives |
| 02/09/2006 | US20060030583 to treat diseases mediated by kinase activity; for example: 2-diethylamino-5-[3-(2-methoxy-phenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethyl-nicotinamide |
| 02/09/2006 | US20060030577 Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
| 02/09/2006 | US20060030573 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
| 02/09/2006 | US20060030555 Imidazo(1,2-a)pyrazine compounds; cancers |
| 02/09/2006 | US20060030553 Cell adhesion inhibitors |
| 02/09/2006 | US20060030543 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/09/2006 | CA2576112A1 Piperidine derivatives as histamine h3 receptor ligands |
| 02/09/2006 | CA2576109A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 02/09/2006 | CA2575345A1 5-substituted 1h-pyrrolo[3,2-b]pyridines |
| 02/09/2006 | CA2575100A1 Heterocyclic compounds |
| 02/09/2006 | CA2573573A1 Fused ring heterocycle kinase modulators |
| 02/09/2006 | CA2573362A1 Pyrrolo-pyridine kinase modulators |
| 02/08/2006 | EP1623973A1 Platinum complex |
| 02/08/2006 | EP1623721A1 Effector cell function inhibitor |
| 02/08/2006 | EP1622910A1 Fused pyrimidine derivatives with crf activity |
| 02/08/2006 | EP1622909A1 Cannabinoid receptor ligands and uses thereof |
| 02/08/2006 | EP1622907A1 Azabicyclononene derivatives |
| 02/08/2006 | EP1622906A1 Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors |
| 02/08/2006 | EP1622905A1 Imidazopyridine intermediates |
| 02/08/2006 | EP1622904A1 Cannabinoid receptor ligands and uses thereof |
| 02/08/2006 | EP1622903A1 Cannabinoid receptor ligands and uses thereof |
| 02/08/2006 | EP1622902A1 Cannabinoid receptor ligands and uses thereof |
| 02/08/2006 | EP1622872A1 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 02/08/2006 | EP1622870A2 Glutaminyl based dp iv-inhibitors |
| 02/08/2006 | EP1622867A1 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 02/08/2006 | EP1622615A2 Naphthyridine integrase inhibitors |
| 02/08/2006 | EP1622610A1 1-(2h-pyrazol-3-yl)-3- 4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl -urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations |
| 02/08/2006 | EP1622569A2 Aza spiro alkane derivatives as inhibitors of metallproteases |
| 02/08/2006 | EP1622564A2 Diazabicyclononene derivatives |
| 02/08/2006 | EP1257278B1 The use of mirtazapine for the treatment of sleep disorders |
| 02/08/2006 | EP0988045B1 Peptide nucleic acid monomers and oligomers |
| 02/08/2006 | CN1732171A Pyridopyrrolizine and pyridoindolizine derivatives |
| 02/08/2006 | CN1732170A Fungicides |
| 02/08/2006 | CN1732169A Naphthyridine derivatives and their use as fungicides |
| 02/08/2006 | CN1732168A Pyridodiazines as plant fungicides |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1732154A Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 02/08/2006 | CN1732146A Cycloalkyl inhibitors of potassium channel function |
| 02/08/2006 | CN1730481A 5-aza-indole preparation method |
| 02/08/2006 | CN1240700C Aromatic heterocyclic carboxylic acid derivative, preparing method and application in medicine |
| 02/08/2006 | CN1240382C Medicine combinations using pyridoindolone derivatives and anticancer agent as base |
| 02/07/2006 | US6995269 Guanidinobenzamides |
| 02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |